Literature DB >> 27698343

Green tea reduces body fat via upregulation of neprilysin.

M Muenzner1, N Tappenbeck2,3, F Gembardt2,4, R Rülke1, J Furkert1, M F Melzig5, W-E Siems1, G A Brockmann6, T Walther3,7,8.   

Abstract

BACKGROUND/
OBJECTIVE: Consumption of green tea has become increasingly popular, particularly because of claimed reduction in body weight. We recently reported that animals with pharmacological inhibition (by candoxatril) or genetic absence of the endopeptidase neprilysin (NEP) develop an obese phenotype. We now investigated the effect of green tea extract (in drinking water) on body weight and body composition and the mediating role of NEP. SUBJECTS/
METHODS: To elucidate the role of NEP in mediating the beneficial effects of green tea extract, 'Berlin fat mice' or NEP-deficient mice and their age- and gender-matched wild-type controls received the extract in two different doses (300 or 600 mg kg-1 body weight per day) in the drinking water.
RESULTS: In 'Berlin fat mice', 51 days of green tea treatment did not only prevent fat accumulation (control: day 0: 30.5% fat, day 51: 33.1%; NS) but also reduced significant body fat (green tea: day 0: 27.8%, day 51: 20.9%, P<0.01) and body weight below the initial levels. Green tea reduced food intake. This was paralleled by a selective increase in peripheral (in kidney 17%, in intestine 92%), but not central NEP expression and activity, leading to downregulation of orexigens (like galanin and neuropeptide Y (NPY)) known to be physiological substrates of NEP. Consequently, in NEP-knockout mice, green tea extract failed to reduce body fat/weight.
CONCLUSIONS: Our data generate experimental proof for the assumed effects of green tea on body weight and the key role for NEP in such process, and thus open a new avenue for the treatment of obesity.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27698343     DOI: 10.1038/ijo.2016.172

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  24 in total

1.  Will green tea be even better than black tea to increase coronary flow velocity reserve?

Authors:  Tsung O Cheng
Journal:  Am J Cardiol       Date:  2004-11-01       Impact factor: 2.778

2.  Acute effects of epigallocatechin gallate from green tea on oxidation and tissue incorporation of dietary lipids in mice fed a high-fat diet.

Authors:  M Friedrich; K J Petzke; D Raederstorff; S Wolfram; S Klaus
Journal:  Int J Obes (Lond)       Date:  2011-07-12       Impact factor: 5.095

Review 3.  Tea and cancer prevention: epidemiological studies.

Authors:  Jian-Min Yuan; Canlan Sun; Lesley M Butler
Journal:  Pharmacol Res       Date:  2011-03-23       Impact factor: 7.658

4.  Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults.

Authors:  Ngozi Erondu; Ira Gantz; Bret Musser; Shailaja Suryawanshi; Madhuja Mallick; Carol Addy; Josee Cote; George Bray; Ken Fujioka; Harold Bays; Priscilla Hollander; Sandra M Sanabria-Bohórquez; WaiSi Eng; Bengt Långström; Richard J Hargreaves; H Donald Burns; Akio Kanatani; Takehiro Fukami; Douglas J MacNeil; Keith M Gottesdiener; John M Amatruda; Keith D Kaufman; Steven B Heymsfield
Journal:  Cell Metab       Date:  2006-10       Impact factor: 27.287

5.  Inhibitory activity of a green tea extract and some of its constituents on multidrug resistance-associated protein 2 functionality.

Authors:  M I Netsch; H Gutmann; S Luescher; S Brill; C B Schmidlin; M H Kreuter; J Drewe
Journal:  Planta Med       Date:  2005-02       Impact factor: 3.352

6.  Genetic, sex, and diet effects on body weight and obesity in the Berlin Fat Mouse Inbred lines.

Authors:  Asja Wagener; Armin O Schmitt; Soner Aksu; Werner Schlote; Christina Neuschl; Gudrun A Brockmann
Journal:  Physiol Genomics       Date:  2006-08-15       Impact factor: 3.107

7.  Metabolism and functions of neuropeptide Y.

Authors:  M dos S Medeiros; A J Turner
Journal:  Neurochem Res       Date:  1996-09       Impact factor: 3.996

8.  Induction of neutral endopeptidase (NEP) activity of SK-N-SH cells by natural compounds from green tea.

Authors:  Shereen Ayoub; Matthias F Melzig
Journal:  J Pharm Pharmacol       Date:  2006-04       Impact factor: 3.765

9.  The vasopeptidase inhibitor AVE7688 ameliorates Type 2 diabetic nephropathy.

Authors:  S Schäfer; W Linz; H Vollert; G Biemer-Daub; H Rütten; M Bleich; A E Busch
Journal:  Diabetologia       Date:  2003-11-14       Impact factor: 10.122

10.  Feeding behaviour in galanin knockout mice supports a role of galanin in fat intake and preference.

Authors:  A C Adams; J C Clapham; D Wynick; J R Speakman
Journal:  J Neuroendocrinol       Date:  2007-12-14       Impact factor: 3.627

View more
  6 in total

Review 1.  Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy.

Authors:  Natalia N Nalivaeva; Anthony J Turner
Journal:  Br J Pharmacol       Date:  2019-03-11       Impact factor: 8.739

Review 2.  Herbal Medicine for the Treatment of Obesity: An Overview of Scientific Evidence from 2007 to 2017.

Authors:  Yanfei Liu; Mingyue Sun; Hezhi Yao; Yue Liu; Rui Gao
Journal:  Evid Based Complement Alternat Med       Date:  2017-09-25       Impact factor: 2.629

Review 3.  Neprilysin expression and functions in development, ageing and disease.

Authors:  N N Nalivaeva; I A Zhuravin; A J Turner
Journal:  Mech Ageing Dev       Date:  2020-09-26       Impact factor: 5.432

4.  18KHT01, a Potent Anti-Obesity Polyherbal Formulation.

Authors:  Prakash Raj Pandeya; Ramakanta Lamichhane; Gopal Lamichhane; Kyung-Hee Lee; Hyeong Kyu Lee; Su-Jin Rhee; Hyun-Ju Jung
Journal:  Front Pharmacol       Date:  2021-12-17       Impact factor: 5.810

Review 5.  Neuropeptidergic Control of Feeding: Focus on the Galanin Family of Peptides.

Authors:  P Marcos; R Coveñas
Journal:  Int J Mol Sci       Date:  2021-03-03       Impact factor: 5.923

Review 6.  Studies on prevention of obesity, metabolic syndrome, diabetes, cardiovascular diseases and cancer by tea.

Authors:  Chung Shu Yang; Hong Wang; Zachary Paul Sheridan
Journal:  J Food Drug Anal       Date:  2017-12-01       Impact factor: 6.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.